Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
Sphingosine-1-phosphate (S1P) receptor modulators act on S1PR1 to S1PR5, five G protein-coupled lipid receptors. In 1998 S1P was identified as a ligand of the orphan receptor endothelial differentiation gene 1 (EDG-1), now called S1PR1. FTY720 (fingolimod) was shown in 2002 to be phosphorylated in vivo and to act on four of the five S1P receptors. Two years later, lymphocyte egress from thymus and lymph nodes was found to depend on S1PR1. Ozanimod, BAF312 and ponesimod are further S1PR1-directed modulators, CYM 5442 HCl is a selective S1PR1 agonist and TY-52156 blocks S1PR3. Opaganib inhibits sphingosine kinase 2 (SphK2) and so limits S1P synthesis upstream of the receptors.
BMS-986104 hydrochloride is a selective partial agonist of the S1P1 receptor, involved in modulating sphingosine-1-phosphate signaling pathways. This compound exhibits potential therapeutic effects in the context of autoimmune diseases by influencing lymphocyte trafficking and immune response. It serves as a valuable tool for research aimed at understanding and developing treatments for various autoimmune disorders.
Out of stock
All 3 sizes